BCM
APLT

Bridgeway Capital Management’s Applied Therapeutics APLT Stock Holding History

Bridgeway Capital Management’s Portfolio APLT Stock Details APLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-63,800
Closed -$542K – 1201
2024
Q3 		$542K Sell
63,800
-85,000
-57% -$501K 0.01% 844
2024
Q2 		$695K Sell
148,800
-25,000
-14% -$118K 0.02% 789
2024
Q1 		$1.18M Sell
173,800
-20,000
-10% -$89.8K 0.02% 699
2023
Q4 		$649K Buy
193,800
+50,000
+35% +$124K 0.01% 873
2023
Q3 		$358K Buy
143,800
+25,000
+21% +$41.2K 0.01% 972
2023
Q2 		$152K Hold
118,800
– – ﹤0.01% 1187
2023
Q1 		$96.4K Buy
118,800
+60,000
+102% +$59.1K ﹤0.01% 1244
2022
Q4 		$44.7K Sell
58,800
-50,000
-46% -$39.5K ﹤0.01% 1307
2022
Q3 		$101K Buy
108,800
+50,000
+85% +$60K ﹤0.01% 1262
2022
Q2 		$56K Sell
58,800
-50,000
-46% -$81.9K ﹤0.01% 1275
2022
Q1 		$230K Buy
+108,800
New +$291K ﹤0.01% 1147

Other funds holding APLT

VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Bridgeway Capital Management's APLT Position: Q4 2024 in Review

Bridgeway Capital Management sold out of Applied Therapeutics (APLT) in Q4 2024, closing a stake of 63,800 shares — an estimated $542K sold.

Bridgeway Capital Management first reported a position in APLT in Q1 2022 and held it in 11 quarters. The position peaked at $1.18M in Q1 2024. 119 funds tracked by Wall St. Rank hold APLT as of Q4 2024.

  • Bridgeway Capital Management reported no remaining Applied Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Bridgeway Capital Management sold 63,800 Applied Therapeutics shares in Q4 2024, an estimated $542K.
  • Bridgeway Capital Management first reported a position in Applied Therapeutics in Q1 2022 and held it in 11 quarters.
  • Bridgeway Capital Management's Applied Therapeutics position peaked at $1.18M in Q1 2024.
  • 119 funds tracked by Wall St. Rank held Applied Therapeutics as of Q4 2024.

Based on Bridgeway Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.